Literature DB >> 19360006

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism.

Mary-Elizabeth Patti1, Sander M Houten, Antonio C Bianco, Raquel Bernier, P Reed Larsen, Jens J Holst, Michael K Badman, Eleftheria Maratos-Flier, Edward C Mun, Jussi Pihlajamaki, Johan Auwerx, Allison B Goldfine.   

Abstract

The multifactorial mechanisms promoting weight loss and improved metabolism following Roux-en-Y gastric bypass (GB) surgery remain incompletely understood. Recent rodent studies suggest that bile acids can mediate energy homeostasis by activating the G-protein coupled receptor TGR5 and the type 2 thyroid hormone deiodinase. Altered gastrointestinal anatomy following GB could affect enterohepatic recirculation of bile acids. We assessed whether circulating bile acid concentrations differ in patients who previously underwent GB, which might then contribute to improved metabolic homeostasis. We performed cross-sectional analysis of fasting serum bile acid composition and both fasting and post-meal metabolic variables, in three subject groups: (i) post-GB surgery (n = 9), (ii) without GB matched to preoperative BMI of the index cohort (n = 5), and (iii) without GB matched to current BMI of the index cohort (n = 10). Total serum bile acid concentrations were higher in GB (8.90 +/- 4.84 micromol/l) than in both overweight (3.59 +/- 1.95, P = 0.005, Ov) and severely obese (3.86 +/- 1.51, P = 0.045, MOb). Bile acid subfractions taurochenodeoxycholic, taurodeoxycholic, glycocholic, glycochenodeoxycholic, and glycodeoxycholic acids were all significantly higher in GB compared to Ov (P < 0.05). Total bile acids were inversely correlated with 2-h post-meal glucose (r = -0.59, P < 0.003) and fasting triglycerides (r = -0.40, P = 0.05), and positively correlated with adiponectin (r = -0.48, P < 0.02) and peak glucagon-like peptide-1 (GLP-1) (r = 0.58, P < 0.003). Total bile acids strongly correlated inversely with thyrotropic hormone (TSH) (r = -0.57, P = 0.004). Together, our data suggest that altered bile acid levels and composition may contribute to improved glucose and lipid metabolism in patients who have had GB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19360006      PMCID: PMC4683159          DOI: 10.1038/oby.2009.102

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  38 in total

Review 1.  Deiodinases: implications of the local control of thyroid hormone action.

Authors:  Antonio C Bianco; Brian W Kim
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

2.  Peptide YY levels are elevated after gastric bypass surgery.

Authors:  Jean L Chan; Edward C Mun; Violeta Stoyneva; Christos S Mantzoros; Allison B Goldfine
Journal:  Obesity (Silver Spring)       Date:  2006-02       Impact factor: 5.002

3.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Chikage Mataki; Marcelo A Christoffolete; Brian W Kim; Hiroyuki Sato; Nadia Messaddeq; John W Harney; Osamu Ezaki; Tatsuhiko Kodama; Kristina Schoonjans; Antonio C Bianco; Johan Auwerx
Journal:  Nature       Date:  2006-01-08       Impact factor: 49.962

4.  Cholestyramine treatment reduces postprandial but not fasting serum bile acid levels in humans.

Authors:  B Angelin; I Björkhem; K Einarsson; S Ewerth
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

5.  Bowel habits and bile acid malabsorption in the months after cholecystectomy.

Authors:  Gerd H Sauter; Ahmed C Moussavian; Guenther Meyer; Heinrich O Steitz; Klaus G Parhofer; Dieter Jüngst
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

6.  Internal biliary diversion improves glucose tolerance in the rat.

Authors:  G Manfredini; M Ermini; L Scopsi; F Bonaguidi; E Ferrannini
Journal:  Am J Physiol       Date:  1985-10

Review 7.  Endocrine functions of bile acids.

Authors:  Sander M Houten; Mitsuhiro Watanabe; Johan Auwerx
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

8.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

Authors:  Michael K Badman; Pavlos Pissios; Adam R Kennedy; George Koukos; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

9.  Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.

Authors:  Hiroyuki Sato; Antonio Macchiarulo; Charles Thomas; Antimo Gioiello; Mizuho Une; Alan F Hofmann; Régis Saladin; Kristina Schoonjans; Roberto Pellicciari; Johan Auwerx
Journal:  J Med Chem       Date:  2008-02-29       Impact factor: 7.446

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  261 in total

1.  Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.

Authors:  Mitsuhiro Watanabe; Yasushi Horai; Sander M Houten; Kohkichi Morimoto; Taichi Sugizaki; Eri Arita; Chikage Mataki; Hiroyuki Sato; Yusuke Tanigawara; Kristina Schoonjans; Hiroshi Itoh; Johan Auwerx
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity.

Authors:  Tiangang Li; Jessica M Francl; Shannon Boehme; Adrian Ochoa; Youcai Zhang; Curtis D Klaassen; Sandra K Erickson; John Y L Chiang
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

Review 3.  Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Authors:  C Dirksen; N B Jørgensen; K N Bojsen-Møller; S H Jacobsen; D L Hansen; D Worm; J J Holst; S Madsbad
Journal:  Diabetologia       Date:  2012-04-27       Impact factor: 10.122

4.  Mid to distal small bowel resection with the preservation of the terminal ileum improves glucose homeostasis in diabetic rats by activating the hindgut-dependent mechanism.

Authors:  Jinyuan Duan; Jianping Zhou; Feng Ren; Cai Tan; Shaohua Wang; Lianwen Yuan
Journal:  J Gastrointest Surg       Date:  2014-04-01       Impact factor: 3.452

5.  Bile acid signaling and bariatric surgery.

Authors:  Jingyan Tian; Silvia Huang; Siming Sun; Lili Ding; Eryun Zhang; Wendong Huang
Journal:  Liver Res       Date:  2017-12

Review 6.  Mechanisms of weight loss and improved metabolism following bariatric surgery.

Authors:  Christopher M Mulla; Roeland J W Middelbeek; Mary-Elizabeth Patti
Journal:  Ann N Y Acad Sci       Date:  2017-09-03       Impact factor: 5.691

7.  Effect of gastric bypass combined with ileal transportation on type 2 diabetes mellitus.

Authors:  Zhaoxia Gao; Bin Wang; Xiaojun Gong; Chun Yao; Defa Ren; Liwei Shao; Yan Pang; Jinxiu Liu
Journal:  Exp Ther Med       Date:  2018-03-06       Impact factor: 2.447

8.  Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin.

Authors:  Marlene Wewalka; Mary-Elizabeth Patti; Corinne Barbato; Sander M Houten; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

9.  Early Effects of Sleeve Gastrectomy on Obesity-Related Cytokines and Bile Acid Metabolism in Morbidly Obese Japanese Patients.

Authors:  Hideharu Shimizu; Fumihiko Hatao; Kazuhiro Imamura; Kijuro Takanishi; Motoyoshi Tsujino
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

Review 10.  Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Authors:  Guy Bower; Tania Toma; Leanne Harling; Long R Jiao; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.